• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchEnveric Biosciences
    Picture of Enveric Biosciences logo

    ENVB — Enveric Biosciences News Story

    $1.400.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    • Market Cap
      $6.27m
    • Enterprise Value
      -$2.03m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ENVB Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ENVB Dividends
    All News

    NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:33 AM

    Picture of Enveric Biosciences logoEnveric Biosciences
    30/04/2026 14:33
    NASDAQ TRADE HALT  ENVB.O  VOLATILITY TRADING PAUSE AT 09:33 AM
    

    Recent news on Enveric Biosciences

    See all news
    • Brief: Enveric Biosciences Announces Positive Results From IND-Enabling ADMET Studies

      21/10/2026 13:29
    • Enveric Biosciences Q2 net loss widens

      14/08/2026 21:17
    • AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer

      16/07/2026 11:32
    • Brief: Enveric Biosciences Initiates Investigational New Drug (IND)-Enabling Genotoxicity Studies Of Lead Neuroplastogen Candidate EB-003

      02/06/2026 13:04
    • Brief: Enveric Biosciences Reports Positive Preclinical Results From Phototoxicity Analysis For Lead Neuroplastogen Candidate Eb-003

      19/05/2026 13:41

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.